These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 18165284

  • 1. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
    Collett-Solberg PF, Misra M, Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society.
    J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-I (rhIGF-I) therapy of short stature.
    Rosenbloom AL.
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):301-15. PubMed ID: 18556960
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
    Richmond EJ, Rogol AD.
    Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
    Clark RG.
    Horm Res; 2004 Dec; 62 Suppl 1():93-100. PubMed ID: 15761240
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL.
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant IGF-I: Past, present and future.
    Bright GM.
    Growth Horm IGF Res; 2016 Jun; 28():62-5. PubMed ID: 26822565
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
    Kemp SF.
    BioDrugs; 2009 Jun; 23(3):155-63. PubMed ID: 19627167
    [Abstract] [Full Text] [Related]

  • 10. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Allen L, Rosenfeld RG.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
    Bright GM, Mendoza JR, Rosenfeld RG.
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
    Midyett LK, Rogol AD, Van Meter QL, Frane J, Bright GM, MS301 Study Group.
    J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
    Nakae J, Kato M, Murashita M, Shinohara N, Tajima T, Fujieda K.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.